The treatment of hepatocellular carcinoma is of ongoing interest for many medical specialties because of its interdisciplinary approach and the range of available modalities. Surgical, locoregional, and systemic therapies can be applied, either alone or in combination. Hepatocellular carcinoma is the most common form of liver cancer. Incidence of the disease has increased in past decades and successful treatment results have been seen with the use of tyrosine kinase inhibitors. However, a parado ...

      Fulltext